3-iodobenzylguanidine has been researched along with Local Neoplasm Recurrence in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (9.76) | 18.7374 |
1990's | 17 (20.73) | 18.2507 |
2000's | 26 (31.71) | 29.6817 |
2010's | 19 (23.17) | 24.3611 |
2020's | 12 (14.63) | 2.80 |
Authors | Studies |
---|---|
Braunstein, SE; DuBois, SG; Fishel Ben Kenan, R; Haas-Kogan, DA; Hawkins, RA; Matthay, KK; Polishchuk, AL | 1 |
Batra, V; Carlin, S; Elias, J; Groff, D; Hou, C; Li, Y; Makvandi, M; Maris, JM; Martinez, D; Martorano, P; Pawel, B; Pryma, DA; Ranieri, P; Samanta, M; Tsang, M; Vaidyanathan, G | 1 |
Bajnok, L; Benkő, I; Bódis, B; Gulyás, E; Kálmán, E; Kittka, B; Mezősi, E; Nemes, O; Schmidt, E; Semjén, D; Szabados, S; Szukits, S | 1 |
Budny, B; Czepczyński, R; Dziuk, M; Majchrzak-Hernandez, M; Ruchała, M; Sawicka-Gutaj, N; Sałyga, A; Szczepanek-Parulska, E | 1 |
Badel, JN; Bogart, E; Corradini, N; Cougnenc, O; Courbon, F; Defachelles, AS; Deley, MCL; Gambart, M; Giraudet, AL; Kolesnikov-Gauthier, H; Oudoux, A; Rault, E; Schleiermacher, G; Sevrin, F; Valteau-Couanet, D | 1 |
Bán, Z; Csernus, K; Gilitsch, A; Mezősi, E; Ottóffy, G; Vojcek, Á | 1 |
Batra, V; DuBois, SG; Gikandi, A; Granger, MM; Marachelian, A; Maris, JM; Martinez, D; Matthay, KK; Park, JR; Pawel, B; Vo, KT | 1 |
Inoue, M; Kusunoki, M; Nagano, Y; Otake, K; Uchida, K | 1 |
Clement, SC; Klein Hesselink, MS; Lebbink, CA; Links, TP; Ronckers, CM; Teepen, JC; van Santen, HM | 1 |
Acord, M; Alai, E; Cahill, AM; Edgar, JC; Escobar, F; Maris, JM; Mosse, YP; Pawel, B; Pogoriler, J; Samoyedny, A; Shellikeri, S; Srinivasan, A; States, L; Vatsky, S | 1 |
Berkovich, R; Cohn, SL; Czarnecki, S; DuBois, SG; Goldsmith, KC; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Irwin, MS; Ji, L; Marachelian, A; Maris, JM; Matthay, KK; Mosse, YP; Park, JR; Pinto, N; Shamirian, A; Shimada, H; Shusterman, S; Tsao-Wei, D; Twist, CJ; Villablanca, JG; Vo, KT; Weiss, B; Yanik, GA | 1 |
Deyell, RJ; Farfan, M; Irwin, MS; Moorehead, PC; Morgenstern, DA; Portwine, C; Rafael, MS; Shammas, A; Usmani, N; Vali, R; Vanniyasingam, T | 1 |
Bhattacharya, D; Koratala, A; Wakefield, DN | 1 |
Goldsmith, SJ; Jensen, J; Lin, T; Noto, RB; Pryma, DA; Stambler, N; Strack, T; Wong, V | 1 |
Fletcher, JI; Haber, M; Marshall, GM; Norris, MD; Trahair, TN; Ziegler, DS | 1 |
Echebarria, A; Genolla, J; Llorens, V; Lopez-Almaraz, R; Minguez, P; Rodriguez, T | 1 |
Gotoh, M; Kato, M; Kobayashi, H; Matsukawa, Y; Yamamoto, T; Yamauchi, Y; Yoshino, Y | 1 |
Behfar, M; Beiki, D; Eftekhari, M; Fallahi, B; Fard-Esfahani, A; Ghavamzadeh, A; Hamidieh, AA; Hosseini, AS; Paragomi, P; Shamshiri, A | 1 |
Bagatell, R; DuBois, SG; Haas-Kogan, DA; Hamilton, J; Hawkins, RA; Hill-Kayser, C; Lau, M; Lemons, RS; Li, R; Little, A; Marcus, KJ; Matthay, KK; Polishchuk, AL; Strahlendorf, C; Tran, HC; Weinberg, V | 1 |
Chen, E; Cohn, SL; Courtier, J; Czarnecki, S; DuBois, SG; Geier, E; Giacomini, K; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Hawkins, R; Jackson, H; Marachelian, A; Matthay, KK; Park, JR; Shimada, H; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yang, X; Yanik, GA | 1 |
Doral, MY; DuBois, SG; Matthay, KK; Villablanca, JG; Yanik, GA; Zhou, MJ | 1 |
Carpentier, P; Clisant, S; Cougnenc, O; Defachelles, AS; Kolesnikov-Gauthier, H; Lervat, C; Oudoux, A | 1 |
Al-Sayegh, H; Bagatell, R; Diller, L; DuBois, S; Haas-Kogan, DA; Hawkins, R; Hill-Kayser, C; Lee, SW; Li, R; London, WB; Marcus, KJ; Matthay, KK; Polishchuk, A; Shusterman, S | 1 |
Cammilleri, S; Colavolpe, C; Coze, C; Guedj, E; Mundler, O; Taïeb, D | 1 |
Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
Barnes, N; Kokai, G; Losty, P; Mc Dowell, H | 1 |
Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
Cross, SF; Dalla Pozza, L; Munns, CF | 1 |
Békássy, AN; Dykes, JH; Garkavij, M; Gleisner, KS; Juliusson, G; Lenhoff, S; Ora, I; Scheding, S; Tennvall, J; Toporski, J; Turkiewicz, D | 1 |
Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
Barbaric, D; Cohn, RJ; Marshall, GM; O'Brien, TA; Russell, SJ; Satharasinghe, K; Trahair, TN; Ziegler, DS | 1 |
Benn, DE; Delbridge, LW; Meyer-Rochow, GY; Roach, PJ; Robinson, BG; Schembri, GP; Sidhu, SB; Sywak, MS | 1 |
Deng, JH; Li, HZ; Liu, GH; Zhang, YS | 1 |
Augustine, T; Davis, JR; Forgacs, B; Heap, S; Howell, SJ; Kirkman, MA; McWilliam, L; Prescott, M | 1 |
Aldridge, M; Almuhaideb, A; Bomanji, JB; Gaze, MN; Papathanasiou, ND; Sullivan, K; Waddington, W | 1 |
Baniewicz, D; Johnson, K; Maris, JM; McGlynn, B; Mosse, YP; Saggio, J; Zhuang, H | 1 |
Ames, MM; Buhrow, SA; Cohn, SL; Jackson, H; Kitchen, BJ; London, WB; McGovern, RM; McGrady, P; Naranjo, A; Parisi, MT; Reid, JM; Reynolds, CP; Shulkin, B; Sondel, PM; Stranzinger, E; Villablanca, JG; Yanik, GA | 1 |
Babich, J; Barrett, J; Daldrup-Link, H; Dubois, SG; Goodarzian, F; Groshen, S; Hawkins, R; Jackson, H; Lafrance, N; Maris, JM; Matthay, KK; Panigrahy, A; Shimada, H; Stubbs, J; Towbin, A; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yanik, GA | 1 |
Arisaka, O; Fukuoka, M; Fukushima, K; Hagisawa, S; Inaki, A; Kayano, D; Kinuya, S; Kurosawa, H; Nakamura, A; Okuya, M; Sato, Y; Sugita, K; Wakabayashi, H | 1 |
Argov, S; Lantsberg, S; Liel, Y; Zirkin, HJ; Zucker, G | 1 |
Brauckhoff, M; Dralle, H | 1 |
Ezuddin, S; Fragkaki, C | 1 |
Aoi, S; Fumino, S; Iwai, N; Shimotake, T; Tsuda, T | 1 |
Charron, M; Cheng, SC; Franc, BL; Hawkins, RA; Maris, JM; Matthay, KK; Messina, JA; Shulkin, B; To, B; Yanik, G | 1 |
Ben Abdallah, N; Cheikhrouhou, H; Chérif, L; Hadj Ali, I; Héni, M; Khiari, K; Rajhi, H | 1 |
Barsaoui, S; Ben Brahim, H; Gharssallah, L; Hammami, H; Hassine, L; Mhiri, A; Oubich, F; Sellem, A | 1 |
Huang, W; Lew, JI; Montano, R; Prinz, RA; Sleeman, D; Solorzano, CC; Sumner, W; Wilhelm, SM; Wu, W | 1 |
Alamán Orbañanos, B; Becerra Cayetano, A; Martín-Romo Capilla, J; Negrete Calderón, N | 1 |
Berthold, F; Hero, B; Schicha, H; Schmidt, M; Simon, T | 1 |
Francis, IR; Glazer, GM; Gross, BH; Shapiro, B; Sisson, JC | 1 |
Kalff, V; Kelly, MJ; McGrath, B | 1 |
De Kraker, J; Hoefnagel, CA; Tiel-van Buul, MM; van der Kleij, AJ; Van Gennip, H; Voûte, PA | 1 |
Bihl, H; Dörr, U; Sautter-Bihl, ML; Schilling, F; Treuner, J | 1 |
Francis, IR; Gonzalez, CE; Leach, K; Shapiro, B; Shulkin, B; Weissman, AF | 1 |
Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
Castle, VP; Hutchinson, RJ; Shapiro, B; Shulkin, BL; Sisson, JC; Yanik, GA | 1 |
van der Kleij, AJ; Voûte, PA | 1 |
De Sio, L; Deb, G; Di Giuda, D; Donfrancesco, A; Giordano, A; Petrone, A; Rufini, V; Troncone, L | 1 |
Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
Luzi, S; Mastrangelo, R; Riccardi, R; Rufini, V; Troncone, L | 1 |
Diociaiuti, L; Mastrangelo, S; Riccardi, R; Rufini, V; Tornesello, A; Troncone, L | 1 |
de Kraker, J; Heij, HA; Rutgers, EJ; Vos, A | 1 |
Bollen, A; Franks, LM; Matthay, KK; Seeger, RC; Stram, DO | 1 |
Andrich, MP; Majd, M; Movassaghi, N; Shalaby-Rana, E | 1 |
Farahati, J; Reiners, C | 1 |
Alonso Rodríguez, M; Castejón Sánchez, I; Escribano Arias, M; Freile García, I; Mariño Pfeiffer, E; Martínez García, G; Ortiz Berrocal, J; Peiró Valgañón, V; Ramos Sanz, J | 1 |
Doi, K; Komori, T; Narabayashi, I; Sueyoshi, K; Tatsu, Y; Utsunomiya, K | 1 |
Amstutz, H; Buitenhuis, CK; Carrel, F; de Kraker, J; Hoefnagel, CA; Meli, M; Novak-Hofer, I; Rutgers, M; Schubiger, PA; Smets, LA | 1 |
Doppman, JL; Eisenhofer, G; Goldstein, DS; Pacak, K; Shulkin, BL; Udelsman, R | 1 |
Fukuchi, K; Hayashida, K; Horita, Y; Inenaga, T; Ishida, Y; Suzuki, Y | 1 |
Buhl, T; Kjaer, A; Mortensen, J | 1 |
Bares, R; Geiger, L; Haase, B; Handgretinger, R; Müller-Schauenburg, W; Niethammer, D; Reuland, P; Thelen, MH | 1 |
Allen, B; Burt, MG; Conaglen, JV | 1 |
Kikkawa, M; Kubota, T; Nakamura, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
Berthold, F; Feine, U; Fischer, M; Klingebiel, T; Maul, FD; Niethammer, D; Schwabe, D; Treuner, J; Waters, W; Wehinger, H | 1 |
Ahuja, S; Ernst, H; Koppenhagen, K | 1 |
Dopfer, R; Ehninger, G; Feine, U; Keller, KD; Klingebiel, T; Niethammer, D; Treuner, J | 1 |
Arai, K; Kondo, M; Shimizu, H; Shimono, Y; Yagi, M; Yuzuki, Y | 1 |
Clarke, SE; Lazarus, CR; Maisey, MN | 1 |
Chenevert, TL; Francis, IR; Glazer, GM; Quint, LE; Shapiro, B | 1 |
Brown, ML; Gharib, H; Grant, CS; Sheps, SG; Sizemore, GW; Swensen, SJ; van Heerden, JA | 1 |
de Kraker, J; Hoefnagel, CA; Marcuse, HR; Voute, PA | 1 |
3 review(s) available for 3-iodobenzylguanidine and Local Neoplasm Recurrence
Article | Year |
---|---|
Too many targets, not enough patients: rethinking neuroblastoma clinical trials.
Topics: 3-Iodobenzylguanidine; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Agents, Immunological; Clinical Trials as Topic; GTP Phosphohydrolases; Humans; Immunotherapy; Membrane Proteins; Molecular Targeted Therapy; Mutation; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neuroblastoma; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Radiotherapy; Risk Assessment; Sample Size; X-linked Nuclear Protein | 2018 |
[Recurrent operations on the adrenal glands].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymph Node Excision; Male; Middle Aged; Mitotane; Neoplasm Recurrence, Local; Octreotide; Palliative Care; Paraneoplastic Endocrine Syndromes; Pheochromocytoma; Radiotherapy, Adjuvant; Reoperation | 2005 |
[Nuclear medicine diagnosis of pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity | 1997 |
13 trial(s) available for 3-iodobenzylguanidine and Local Neoplasm Recurrence
Article | Year |
---|---|
Phase II study of
Topics: 3-Iodobenzylguanidine; Adolescent; Busulfan; Child; Child, Preschool; Chronic Disease; Humans; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Topotecan; Young Adult | 2023 |
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infant; Irinotecan; Male; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine; Vorinostat; Young Adult | 2021 |
Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Prognosis; Survival Rate | 2018 |
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Acetylation; Adolescent; Adult; Aged; Child; Child, Preschool; Drug Monitoring; Female; Histones; Humans; Hydroxamic Acids; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiation-Sensitizing Agents; Treatment Outcome; Vorinostat; Young Adult | 2015 |
HIGH-DOSE 131I-MIBG THERAPIES IN CHILDREN: FEASIBILITY, PATIENT DOSIMETRY AND RADIATION EXPOSURE TO WORKERS AND FAMILY CAREGIVERS.
Topics: 3-Iodobenzylguanidine; Adult; Caregivers; Child; Female; France; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiation Exposure; Radiometry; Topoisomerase I Inhibitors; Topotecan | 2017 |
The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2010 |
Safety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Brain Neoplasms; Female; Humans; Infusions, Intravenous; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Treatment Outcome | 2011 |
Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adolescent; Antineoplastic Agents; Capsules; Child; Child, Preschool; Disease-Free Survival; Female; Fenretinide; Humans; Infant; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2011 |
The prognostic impact of functional imaging with (123)I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: results of the German Neuroblastoma Trial NB97.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Stem Cell Transplantation; Treatment Outcome | 2008 |
Clinical experience with radiation enhancement by hyperbaric oxygen in children with recurrent neuroblastoma stage IV.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Humans; Hyperbaric Oxygenation; Infant; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiation Tolerance; Survival Rate | 1995 |
Survival of patients with neuroblastoma treated with 125-I MIBG.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Platelet Count; Remission Induction; Survival Rate; Treatment Outcome | 1996 |
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Contrast Media; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Tomography, Emission-Computed | 1996 |
Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2002 |
66 other study(ies) available for 3-iodobenzylguanidine and Local Neoplasm Recurrence
Article | Year |
---|---|
Anatomic patterns of relapse and progression following treatment with
Topics: 3-Iodobenzylguanidine; Disease Progression; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Retrospective Studies | 2022 |
Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma.
Topics: 3-Iodobenzylguanidine; Alpha Particles; Animals; Astatine; Guanidines; Humans; Iodine Radioisotopes; Mice; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured | 2022 |
Diagnostic difficulties and therapeutic options of a giant chest paraganglioma
Topics: 3-Iodobenzylguanidine; Adult; Humans; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Paraganglioma | 2022 |
[131I]I-MIBG-negative metastases of a recurrent sporadic paraganglioma in a female with achondroplasia.
Topics: 3-Iodobenzylguanidine; Achondroplasia; Adrenal Gland Neoplasms; Female; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography | 2023 |
[131-I-meta-iodo-benzyl-guanidine therapy in childhood neuroblastoma.]
Topics: 3-Iodobenzylguanidine; Adult; Child; Child, Preschool; Guanidines; Humans; Neoplasm Recurrence, Local; Neuroblastoma | 2023 |
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to
Topics: 3-Iodobenzylguanidine; Chronic Disease; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Vesicular Monoamine Transport Proteins | 2024 |
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Basic Helix-Loop-Helix Transcription Factors; Humans; Kidney Neoplasms; Male; Mutation; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Polycythemia; Radionuclide Imaging; Radiopharmaceuticals; Young Adult | 2020 |
Presentation and outcome of subsequent thyroid cancer among childhood cancer survivors compared to sporadic thyroid cancer: a matched national study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Age of Onset; Antineoplastic Agents; Biopsy; Cancer Survivors; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Radiopharmaceuticals; Retrospective Studies; Self Report; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Ultrasonography; Young Adult | 2020 |
Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Correlation of Data; Female; Humans; Image-Guided Biopsy; Infant; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Single Photon Emission Computed Tomography Computed Tomography; Whole Genome Sequencing; Young Adult | 2021 |
Residual meta-iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome.
Topics: 3-Iodobenzylguanidine; Guanidine; Humans; N-Myc Proto-Oncogene Protein; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies | 2021 |
Benign-Appearing Pheochromocytoma With Late Recurrence.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Medulla; Biopsy; Chromaffin Cells; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2017 |
Dosimetry-based high-activity therapy with
Topics: 3-Iodobenzylguanidine; Adolescent; Chemoradiotherapy; Child; Child, Preschool; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Progression-Free Survival; Radiometry; Recurrence; Remission Induction; Retrospective Studies; Risk; Topotecan; Treatment Outcome; Young Adult | 2019 |
[A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY].
Topics: 3-Iodobenzylguanidine; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dacarbazine; Disease-Free Survival; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Neoplasm Recurrence, Local; Paraganglioma; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Urinary Bladder Neoplasms; Urinary Diversion; Vincristine | 2018 |
The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: a pilot study.
Topics: 3-Iodobenzylguanidine; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Prognosis; Prospective Studies; Radionuclide Imaging; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2014 |
Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Induction Chemotherapy; Infant; Iodine Radioisotopes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2014 |
Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Infant; Iodine Radioisotopes; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Female; Humans; Induction Chemotherapy; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Risk; Statistics, Nonparametric; Stem Cell Transplantation; Transplantation, Autologous; Whole-Body Irradiation | 2017 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Endocrine Surgical Procedures; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2009 |
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone and Bones; Bone Marrow; Catecholamines; Disease-Free Survival; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2009 |
Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child; Humans; Hypercalcemia; Isotretinoin; Male; Neoplasm Recurrence, Local; Neuroblastoma; Osteoblasts | 2009 |
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Cell Culture Techniques; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Mesenchymal Stem Cell Transplantation; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals; T-Lymphocytes; Transplantation Chimera | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
False-positive MIBG scans with normal computed tomography imaging in patients with high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; False Positive Reactions; Female; Humans; Male; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Risk Factors; Tomography, X-Ray Computed | 2009 |
Functional paragangliomas of the urinary bladder: a report of 9 cases.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Catecholamines; Chromogranin A; Cystectomy; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paraganglioma; S100 Proteins; Tomography, X-Ray Computed; Urinary Bladder Neoplasms; Young Adult | 2010 |
Third resection of pheochromocytoma aided by preoperative ¹²³I-MIBG scintigraphy and intraoperative gamma probe measurements.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Surgery, Computer-Assisted; Treatment Outcome | 2011 |
18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival; Survival Analysis; Tomography, Emission-Computed; Young Adult | 2011 |
Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Brain Neoplasms; Chemistry, Pharmaceutical; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neuroblastoma; Quality of Life; Radiation Dosage; Radiometry; Radiopharmaceuticals; Software; Tissue Distribution; Tomography, X-Ray Computed; Young Adult | 2012 |
I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Fatal Outcome; Female; Humans; Infant; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Radiopharmaceuticals | 2012 |
Malignant pheochromocytoma simulating meningioma: coexistence of recurrent meningioma and metastatic pheochromocytoma in the base of the skull.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Antineoplastic Agents; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pheochromocytoma; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed | 2002 |
MIBG and FDG PET findings in a patient with malignant pheochromocytoma: a significant discrepancy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Patient Care Planning; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B.
Topics: 3-Iodobenzylguanidine; Adolescent; Carcinoma, Medullary; Child; Female; Follow-Up Studies; Humans; Multiple Endocrine Neoplasia Type 2b; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2005 |
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Infant, Newborn; Male; Neoplasm Recurrence, Local; Neuroblastoma; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results | 2006 |
[Malignant pheochromocytomas: about three cases].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoma, Papillary; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms | 2006 |
[Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Agents; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Outcomes of pheochromocytoma management in the laparoscopic era.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Aged, 80 and over; Child; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Laparoscopy; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Retrospective Studies; Tomography, X-Ray Computed | 2007 |
[Anesthetic management in a case of recurrent mediastinal paraganglioma].
Topics: 3-Iodobenzylguanidine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, General; Combined Modality Therapy; Female; Fluid Therapy; Humans; Hypertension; Intraoperative Complications; Iodine Radioisotopes; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Phenoxybenzamine; Preanesthetic Medication; Propranolol; Spinal Fusion; Spinal Neoplasms; Thoracic Vertebrae; Thoracotomy | 2008 |
Complementary roles of CT and 131I-MIBG scintigraphy in diagnosing pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Diphosphonates; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Recurrence, Local; Pentetic Acid; Pheochromocytoma; Retrospective Studies; Sympatholytics; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pentetate; Tomography, X-Ray Computed | 1983 |
Scintigraphic localization of a recurrent phaeochromocytoma by means of iodine-131 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Pheochromocytoma; Radionuclide Imaging | 1984 |
Somatostatin receptor imaging: a new horizon in the diagnostic management of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Chromosome Deletion; Chromosomes, Human, Pair 1; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Octreotide; Pentetic Acid; Ploidies; Prognosis; Radionuclide Imaging; Receptors, Somatostatin; Survival Rate | 1994 |
Multiple chemodectomas. Carotid body tumor masked by salivary gland uptake on I-123 MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Carotid Body Tumor; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma, Extra-Adrenal; Salivary Glands; Tomography, Emission-Computed, Single-Photon | 1994 |
Treatment of recurrent stage IV neuroblastomas with 131I-MIBG and HBO Six years follow-up.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Follow-Up Studies; Humans; Hyperbaric Oxygenation; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neuroblastoma; Survival Rate; Time Factors | 1996 |
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Bone Marrow Neoplasms; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Pheochromocytoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Remission Induction; Survival Rate | 1995 |
The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction; Survival Rate | 1995 |
Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease Progression; Hematologic Diseases; Hemorrhage; Humans; Infant; Infections; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction | 1995 |
Intraoperative search for neuroblastoma by MIBG and radioguided surgery with the gamma detector.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Contrast Media; Feasibility Studies; Humans; Intraoperative Period; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Neuroblastoma; Pilot Projects; Radionuclide Imaging; Radiosurgery; Reoperation | 1997 |
Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Topics: 3-Iodobenzylguanidine; Actuarial Analysis; Adolescent; Adult; Age Factors; Catecholamines; Child; Child, Preschool; Contrast Media; Disease-Free Survival; Female; Gene Amplification; Genes, myc; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Treatment Outcome | 1997 |
In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Cause of Death; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Ganglioneuroblastoma; Gene Amplification; Genes, myc; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
[Eight year history of neuroblastoma in an adult patient. Value of 123I-MIBG and 111In-DTPA-D-Phe-octreotide scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Biomarkers, Tumor; Bone Marrow; Bone Neoplasms; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neuroblastoma; Octreotide; Pentetic Acid; Prognosis; Radionuclide Imaging; Receptors, Somatostatin | 1999 |
A case of local recurrent pheochromocytoma: usefulness of I-123 MIBG early SPECT and maximum intensity projection images.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed, Single-Photon | 2000 |
A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Animals; Antibodies, Monoclonal; Antigens, Surface; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Infant; Leukocyte L1 Antigen Complex; Male; Membrane Glycoproteins; Mice; Mice, Nude; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neural Cell Adhesion Molecules; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Transplantation, Heterologous; Tumor Cells, Cultured; Whole-Body Counting | 2001 |
A "pheo" lurks: novel approaches for locating occult pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Carrier Proteins; Dopamine; Epinephrine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Normetanephrine; Pheochromocytoma; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vena Cava, Inferior | 2001 |
Paraganglioma seen with FDG dual-head gamma camera coincidence imaging after false-negative results of I-123 MIBG imaging.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Paraganglioma; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
I-123 MIBG imaging and intraoperative localization of metastatic pheochromocytoma: a case report.
Topics: 3-Iodobenzylguanidine; Abdomen; Adrenal Gland Neoplasms; Humans; Intraoperative Period; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Pheochromocytoma; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2002 |
Follow-up in neuroblastoma: comparison of metaiodobenzylguanidine and a chimeric anti-GD2 antibody for detection of tumor relapse and therapy response.
Topics: 3-Iodobenzylguanidine; Adolescent; Antibodies, Monoclonal; Bone Neoplasms; Child; Child, Preschool; False Negative Reactions; Female; Fluorescent Antibody Technique; Follow-Up Studies; Gangliosides; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Fusion Proteins; Soft Tissue Neoplasms; Technetium | 2001 |
False positive 131I-metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenalectomy; Adult; False Positive Reactions; Humans; Hyperplasia; Male; Neoplasm Recurrence, Local; Pheochromocytoma; Postoperative Period; Radionuclide Imaging; Radiopharmaceuticals | 2002 |
Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Germany; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Remission Induction; Survival Rate | 1991 |
[The evaluation of 123I-MIBG scintigraphy in medullary thyroid carcinoma (MTC)].
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma; Contrast Media; Drug Evaluation; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radionuclide Imaging; Thyroid Neoplasms; Time Factors | 1990 |
[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Child, Preschool; Dose-Response Relationship, Radiation; Drug Evaluation; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Remission Induction; Time Factors | 1989 |
[A case of familial, benign, recurrent and multiple pheochromocytoma whose 131I-MIBG scintigraphy was false negative].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; False Negative Reactions; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pheochromocytoma; Radionuclide Imaging | 1989 |
Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoma; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Organometallic Compounds; Radionuclide Imaging; Soft Tissue Neoplasms; Succimer; Sulfhydryl Compounds; Technetium; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms | 1987 |
Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Bone Neoplasms; Evaluation Studies as Topic; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Magnetic Resonance Spectroscopy; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 1987 |
Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Bone Neoplasms; Child; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Time Factors; Tomography, X-Ray Computed | 1985 |
Detection of neuroblastoma with 131I-meta-iodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging | 1985 |